Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

FDA, children's ibuprofen

Digest more
Top News
Overview
Highlights
 · 16h
FDA issues urgent, nationwide recall for 85K+ bottles of children’s medicine
More than 89,000 bottles of children’s medication are being recalled after the manufacturer received several complaints that the products contained foreign matter.

Continue reading

FOX6 News Milwaukee · 18h
90,000 bottles of children's ibuprofen recalled nationwide, FDA says
 · 21h
Urgent recall: FDA updates risk level for 90,000 bottles of children’s medicine
 · 15h
Nearly 90,000 bottles of children's liquid pain medication recalled
Nearly 90,000 bottles of a children's pain reliever have been recalled due to reports of black specs and other contaminants, according to federal regulators.

Continue reading

 · 1d
Nearly 90,000 Bottles of Children's Ibuprofen Recalled After Contamination with Foreign Substance
 · 14h
Children's ibuprofen recalled as 'gel-like mass' alleged in product.
 · 1d
Nearly 90,000 bottles of children's ibuprofen recalled. See product.
The recall is for Strides Pharma's 100-miligram Children's Ibuprofen Oral Suspension, sold in a 4-fluid-ounce bottle.

Continue reading

 · 14h
Nearly 90,000 Bottles of Children’s Ibuprofen Were Just Recalled—Here’s Why
 · 1d
Children’s ibuprofen under recall for ‘foreign substance’
17hon MSN

US FDA flags seizure risk with certain Parkinson's drugs, seeks label warnings

March 20 (Reuters) - The U.S. Food and Drug Administration said on Friday it has notified manufacturers of certain Parkinson's disease treatments to update their prescribing information with a new warning about a potential risk of seizures.
9h

Fast-track FDA approval brings stronger Wegovy to pharmacies by April

A stronger 7.2 mg dose of Wegovy wins FDA approval after a 54-day review, promising greater weight loss for eligible patients.
6h

FDA drops proposed rule barring tanning bed use for minors

On Tuesday, the Food and Drug Administration pulled a proposed rule that would have banned anyone under age 18 from using tanning beds.
16hon MSN

US FDA approves Bristol Myers Squibb's cancer drug for Hodgkin's lymphoma

March 20 (Reuters) - The U.S. Food and Drug Administration said on Friday it approved Bristol Myers Squibb's combination treatment for adults and adolescents aged 12 and older with previously untreated stage III or IV classical Hodgkin's lymphoma.
2d

US FDA pushes for new methods to replace animal testing in early drug studies

Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce animal studies of experimental drugs ‌and adopt newer methods, such as computer simulations and devices that mimic functions ‌of human organs.
ConsumerAffairs
21h

FDA approves a higher dose of the weight-loss drug, Wegovy

The FDA has approved a higher 7.2 mg dose of Novo Nordisk’s Wegovy (Wegovy HD) for chronic weight management in adults with obesity. The new dose s
13d

Trump administration's embattled FDA vaccine chief is leaving again

The Food and Drug Administration's embattled vaccine chief, Dr. Vinay Prasad, is once again leaving the agency — the second time in less than a year that he's departed after controversial decisions involving the review of vaccinations and specialty drugs for rare diseases.
3don MSN

FDA: Novo Nordisk failed to report deaths of weight-loss drug patients

Novo Nordisk's reports to the FDA spiked shortly after an inspection found the Ozempic producer ignored reports of deaths and potential side effects.
14d

Trump administration’s embattled FDA vaccine chief is leaving for the second time

WASHINGTON (AP) — The Food and Drug Administration’s embattled vaccine chief, Dr. Vinay Prasad, is once again leaving the agency — the second time in less than a year that he’s departed after controversial decisions involving the review of vaccinations and specialty drugs for rare diseases.
MyChesCo on MSN
5d

FDA launches real-time safety database for drugs and vaccines

WASHINGTON, D.C. — The U.S. Food and Drug Administration has launched a new centralized system that will allow scientists, regulators, and the public to analyze safety reports for drugs, vaccines,
  • Privacy
  • Terms